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 ABSTRACT  
Evolution of a Disintegrin and Metalloproteinase Gene Family in Vertebrates 
Shashwati Bhattacharya 
A disintegrin and metalloproteinases (ADAMs) are a family of transmembrane proteins which 
have diverse functions in various tissues. They play important roles in cellular and 
developmental processes and are present in various species. ADAMs are classified according 
to their expression in tissues into the somatic ADAMs (sADAMs) and the testicular ADAMs 
(tADAMs). The sADAMs are expressed in somatic tissues, and the testicular ADAMs (tADAMs) 
are expressed predominantly in the testis. The tADAMs are further classified into Group I and 
Group II, based on the absence or presence of introns. The mechanism of evolution of the 
tADAMs was unknown. Using bioinformatics tools, we performed an analysis of the evolution of 
ADAM genes in various vertebrates from fish to mammals. Our results show the duplication and 
loss of tADAMs in certain vertebrate species. In our phylogenetic analysis, all the tADAMs 
cluster together with ADAM9 and ADAM9-like, which we identified as a close paralog of ADAM9 
in certain non-mammalian vertebrates, but are more distantly related to other sADAMs. Our 
synteny analysis shows that most Group II tADAMs lie next to the Adam9 gene locus and hence 
likely arose from tandem duplication. On the other hand, Group I tADAMs are intronless, so they 
likely originated through retroposition. Therefore, we hypothesize that ADAM9/9-like and the 
tADAM loci are hotspots of gene duplication because many events of tandem duplication and 
retroposition have occurred in these regions. Some tADAMs were pseudogenized in certain 
species as a result of duplication events. The rapid duplication of ADAM genes resulted in 
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The “A disintegrin and metalloproteinase” (ADAM) family of proteins play important roles in 
cellular and developmental processes. The first two members of the ADAM family were 
identified as guinea pig sperm-surface proteins that were recognized by the monoclonal 
antibody PH-30 (Primakoff et al., 1987). These sperm surface proteins from guinea pig were 
found to have a metalloproteinase-like and a disintegrin-like domain, and are related to the 
family of snake venom protein domains (Blobel et al., 1992; Wolfsberg et al., 1993). These 
proteins were therefore named ADAM for containing “A Disintegrin” and “A Metalloproteinase” 
domain (Wolfsberg et al., 1995).  
ADAMs belong to the metzincin superfamily of proteases (Bode et al., 1996). This superfamily 
of proteases have a zinc binding consensus sequence HExxHxxGxxH that is present in all 
proteolytically active members (Stocker et al., 1995). Zinc-dependent proteases are classified 
into gluzincin, metzincin, inuzincin, carboxypeptidase, and DD carboxypeptidase subgroups 
according to the primary structure of their catalytic sites (Hooper NM. 1994). The ADAMs belong 
to the metzincin subgroup which is subdivided into serralysin, astacin, matrixin, and adamalysin 
(Stocker et al., 1995). The serralysins are a family of proteolytic enzymes that are secreted by 
various bacteria of genus Serratia (Nakahama et al., 1986). Astacins are proteases which are 
found in wide range of organisms and function in processing proteins (Bond et al., 1995). The 
matrixins comprise the matrix metalloproteinases (MMPs). Adamalysins, including ADAMs, 





ADAMs are mainly multi-domain type I transmembrane proteins. Some ADAMs can be present 
in a soluble form because of alternative splicing or protease-mediated cleavage. ADAMs are 
present in invertebrate species such as nematode Caenorhabditis elegans and all vertebrates. 
Adam-like sequences have been found in the yeast Saccharomyces pombe (Edwards et al., 
2008).  
ADAMs are involved in a variety of functions. In mammals, many of the ADAMs are expressed 
in somatic tissues, and are known to have a role in cell fate determination in the central nervous 
system, cell migration, as well as axon and muscle development (Primakoff et al., 2000). 
Functions of ADAMs vary from neural crest development in frogs and chicken, adipogenesis 
and myogenesis in mice, to the fusion of sperm and egg in mice (Rooke et al. 1996; Kurisaki et 
al., 2003; Cousin et al., 2011; Schiffmacher et al., 2014). The main functions of ADAMs are 
proteolysis, adhesion and intercellular signaling. Biological functions of many ADAMs are still 
unknown. ADAMs have been implicated in many diseases, including cancers, immune diseases 
and neurodegenerative diseases (Edwards et al., 2008). For example, ADAM9 is upregulated in 
many cancers and also spreads colon cancer cells by binding to integrins α6β4 and α2β1 
(Edwards et al., 2008). Some ADAMs stimulate cell proliferation via EGFR receptor activation 
and cause growth of malignant tumors (Borroto et al., 2003; Kenny et al., 2007). On the other 
hand, ADAMs can also be used for therapeutics. For example, ADAM10 plays an important role 
in Alzheimer’s disease by participating in non-amyloidogenic processing of amyloid-beta 
precursor protein (APP) and hence helps in alleviating the progress of the disease (Cong et al., 
2009). Therefore, therapies can be developed by either promoting or inhibiting ADAM activities 






1.2. Structure of ADAMs: 
The basic structure of ADAMs consists of a signal peptide, a prodomain (PRO), a 
metalloproteinase domain (MP), a disintegrin domain (DIS), a cysteine-rich domain (CRD), a 
transmembrane region (TM) and a cytoplasmic tail (Figure 1). A signal peptide at the N-terminus 
of an ADAM directs it into the secretory pathway and the prodomain functions as a chaperone to 
facilitate the proper folding and secretion of ADAMs (Roghani et al., 1999). The prodomain also 
prevents self-cleavage by binding and inhibiting the MP domain. A “cysteine switch” in the 
prodomain of some ADAMs function to regulate the MP domain, and hence regulate proteolysis 
(Zhu et al., 1999, Brachvogel et al., 2003). Proprotein convertases cleave the prodomain in the 
Golgi, resulting in activation of ADAM proteases (Schlondorff et al., 1999). The MP domain in 
proteolytically active ADAMs contains a consensus sequence HExxHxxGxxH, which binds the 
catalytic zinc ion. The zinc ion is necessary for hydrolytic processing of protein substrates. A 
‘Met turn’, i.e., a methionine residue C-terminal to this consensus sequence, stabilizes the zinc 
ion and maintains the structure of the active site (Seals et al., 2003). About half of the ADAMs 
lack this consensus sequence in the MP domain, and hence lack the protease activity (Brocker 
et al., 2009). The DIS domain has a disintegrin loop, which is responsible for the interaction with 
integrins (White, 2003). ADAMs, except for ADAM10 and ADAM17, have a Rx6DEVF sequence 
in their DIS domain which interacts with the α9β1 integrin (Eto et al., 2002). The CRD of 
ADAM12 is involved in cell-matrix adhesion by acting as a ligand for syndecan (a cell adhesion 
molecule) (Seals et al., 2003). The CRD of Xenopus ADAM13 has been shown to interact with 
the glycoprotein fibronectin (Gaultier et al., 2002). The cytoplasmic tail varies in length among 
various ADAMs, and may contain binding sites for different proteins (Cho, 2012). Several 
ADAMs have one or more PXXP sites for binding to SH3 motif-containing proteins, which 





interacts with alpha-actinin2, a cytoskeletal protein which binds actin (Cao et al., 2001). Through 
interaction with cellular proteins, the cytoplasmic tail may be involved in intracellular signaling. 
1.3. Functions of ADAMs: 
Some somatic ADAMs play important roles in cell fate determination, cell migration, and axon 
and muscle development (Primakoff et al., 2000). For example, ADAM8 is a transmembrane 
glycoprotein expressed in immune cells, and contributes to neuron-glia interaction in the central 
nervous system (Schlomann et al., 2000). ADAM12-deficient mice have defects in the formation 
of adipose tissue and myogenesis (Kurisaki et al., 2003). Some ADAMs cleave EGFR ligands to 
activate the EGFR pathway which is responsible for cell migration, differentiation and tissue 
homeostasis (Liebmann, 2011, Wong, 2003). For example, ADAM17 is required for the 
shedding of EGFR ligands TGFα, HB-EGF, and amphiregulin, and ADAM10 is involved in 
cleaving two EGFR ligands EGF and betacellulin (Sahin et al., 2004). ADAM10 also processes 
both the N- and E-cadherins, which are involved in physiological functions such as neurulation, 
somitogenesis and tissue morphogenesis (Maretzky et al., 2005, Reiss et al., 2005). ADAM 
proteases also cleave cytokines and cytokine receptors, which play important roles in immune 
responses (Edwards et al., 2008, Jin et al., 2004, Kurzrock 2001). For example, ADAM17 
cleaves TNF-α (tumor necrosis factor alpha), which is a proinflammatory cytokine and regulates 
immune cells (Black 2002). Finally, ADAMs are involved in a process called regulated 
intramembrane proteolysis (RIP). RIP is the cleaving of an integral membrane protein to release 
a soluble protein which is involved in cellular functions like apoptosis, cell proliferation, etc. 
(Edwards et al., 2008). Activation of the Notch receptor is a RIP process and ADAMs participate 
in this process. When the Notch receptor binds to the Notch ligand, it undergoes a series of 
proteolytic cleavages, which release the Notch intracellular domain. Ligand activates Notch and 





membrane-bound “stub” of Notch which is cleaved further at S3 and S4 sites and releases the 
Notch intracellular domain that translocates to the nucleus and acts as a transcription regulator 
(Brou et al., 2000). 
1.4. Classification of tADAMs:  
More than half of the ADAM proteases are predominantly expressed in the male testis. Cho 
(2012) divided the mouse reproductive ADAMs into three groups: (I) intronless tADAMs, (II) 
tADAMs with multiple exons and introns, and (III) ADAM7 and ADAM28. In mice, ADAM7 and 
ADAM28 do not show expression in the testes, but are expressed in the epididymis (Kim et al., 
2006). Phylogenetic analyses indicate that ADAM7 and ADAM28 do not cluster together with 
tADAMs (Figure 2). Group III, which consists of ADAM7 and ADAM28, was removed from the 
list of tADAMs based on these observations (Table 1, with Group III removed). But we keep the 
other two groups of tADAMs, i.e. Group I and Group II, based on their clustering in the 
phylogenetic tree (Figure 2).  
Group I has 11 tAdam genes which lack introns in their coding sequences (Kim et al., 2006). 
ADAMs 4, 6, 24, 25, and 26 are exclusively expressed in germ cells of the mouse testis.  
Group II tADAMs are predominantly expressed in germ cells of the testes. ADAMs in Group II 
lack active protease activity since they lack the consensus sequence of HExxHxxGxxH (Cho, 
2012). There is evidence that some Group II tADAMs are also expressed in somatic tissues 
(Murase et al., 2008). 
1.5. Key roles of ADAMs in fertilization: 
TADAMs play key roles in fertilization, which is initiated by the adhesion of sperm and ovum. In 





zona pellucida, which is a glycoprotein membrane of the ovum (Evans, 2001). ADAM1, ADAM2 
and ADAM3 are essential for sperm-egg fusion (Cerretti et al., 1999). ADAM1 and ADAM2 form 
a heterodimeric complex on the mature sperm (Primakoff et al., 1987; Blobel et al., 1992, 
Wolfsberg et al., 1995, Evans, 2002). ADAM2 and ADAM3 form a complex that helps the sperm 
to enter the oviduct in vivo, and promote sperm–egg interactions in vitro in mice (Cho, 2012). 
Trimeric complexes, such as ADAM2/ADAM3/ADAM4, ADAM2/ADAM3/ADAM5, and 
ADAM2/ADAM3/ADAM6, are formed on matured sperm, and are necessary for successful 
fertilization (Han et al., 2009). ADAM18 is proteolytically processed by cleaving both the pro- 
and metalloproteinase-like domains and retaining the disintegrin-like domain during epididymal 
transit to yield mature proteins on matured sperm (Frayne et al., 1998). ADAM21 is expressed 
in testicular somatic cells as well as germ cells (Yi et al., 2010). The Adam21 gene produces 
two types of transcripts. One is expressed in germ cells of the testis and has exon1 and exon2, 
while the other is expressed in testicular somatic cells and only has exon2 (Yi et al., 2010). It is 
unclear whether ADAM21 is involved in fertilization or spermatogenesis.  ADAM24 is localized 
on the mature sperm acrosome after its prodomain has been removed. The cytoplasmic tail of 
ADAM24 acts as a substrate for protein kinase C (PKC). After activation of ADAM24 by PKC, 
the sperm penetrates the zona pellucida (Zhu et al., 2001). In in vitro assays, Adam24-knockout 
mice displayed reduced fertility with polyspermic fertilization, which can lead to abnormal 
embryonic development (Zhu et al., 2009). ADAM25 and 26 (also called testase2 and testase3) 
are only found to be expressed in mouse spermatogenic process (Zhu et al., 1999, Brachvogel 
et al., 2003). Previous reports suggest that ADAM27 is expressed in the pachytene stage of 
spermatocytes of mice. Adam32 gene expression begins during meiotic prophase in 
spermatocytes (Choi et al., 2003). All of these studies on the reproductive ADAMs were 
performed on rodents. Since some of these genes are pseudogenes in the human genome, it is 






The objective was to understand the mechanism of evolution of tADAMs. We wanted to find 
whether there are tADAMs in non-placental mammals and in non-mammalian vertebrates. 
ADAM9 is a sADAM which is widely expressed and highly conserved among all vertebrates that 
clusters along with the tADAMs in the phylogenetic analyses (Figure 2). We hypothesized that 
all the tADAMs originated from a common ancestor shared with ADAM9. With the help of 
phylogenetic analyses and syntenic analyses, we wanted to explore the evolutionary origin of 
tAdams.  
1.7. Significance of the study:  
The study on the evolution of reproductive ADAMs provided key insights into the functions of 
these proteins and the actual mechanisms of gene duplication. ADAMs are critical for 
fertilization and could be helpful in developing new methods of in vitro fertilization.  
2. MATERIALS AND METHODS 
2.1. Identification of Adam genes in vertebrate 
species tested (i.e. opossum, chick, lizard, and 
frog): 
The sequences of annotated human and mouse ADAMs were used to identify Adam genes from 







earch&LINK_LOC=blasthome) was used to search against the species genome assembly. The 
representative species chosen were opossum, chick, lizard, and frog; other vertebrates such as 
rat, rabbit, pig, dog, Tasmanian devil, platypus, zebra finch, flycatcher, coelacanth, Japanese 
medaka, zebrafish, spotted gar and elephant shark were also included so that there was a 
representative organism from each vertebrate phylum. Three types of analyses i.e. phylogeny, 
synteny, and conservation of intron-exon boundaries were performed to identify the orthologs of 
predicted human and mouse ADAMs. The most appropriate BLAST hit i.e. the most significant 
match between sequences was selected. The lowest and closest to zero E-value is the most 
significant BLAST hit. The BLAST hit with E-value zero was selected, and the UCSC genome 
browser BLAT was used to search and identify the intron-exon boundaries in the tAdam 
genomic sequence (BLAT: https://genome.ucsc.edu/cgi-bin/hgBlat?command=start). Tissue 
expression patterns of specific Adam genes were obtained from the NCBI’s UniGene website.  
2.2. Phylogenetic analyses:  
For phylogenetic analyses, amino acid sequences of ADAM from various species (Table 2) 
were aligned using default MUSCLE (MUltiple Sequence Comparison by Log Expectation) 
alignment parameters, and all positions containing gaps were eliminated (Edgar, 2004). 
Phylogenetic trees, including Bayesian, neighbor joining, and maximum likelihood trees, were 
constructed to investigate the evolutionary relationship among the ADAMs as described below. 
Three types of tree building methods were used to see if the clustering of the clades are 
consistent when the phylogenetic trees are built using different tree building methods. 
The Bayesian Markov Chain Monte Carlo analyses were conducted with MrBayes version 3.2.2 





posterior probability is the probability that the tree is correct and the evolutionary model used in 
the analyses is assumed to be correct. The bases of Bayesian inference is the Bayes’s 
theorem:            
PrTree I Data =
PrData I Tree × PrTree
PrData
 
This equation is used to calculate the posterior probability distribution on trees (Pr[Tree I Data]) 
by combining prior probability of a phylogeny (Pr[Tree]) with the likelihood (Pr[Data I Tree]). This 
suggests that the tree with higher posterior probability will be the favorable data for interpreting 
the phylogeny (Huelsenbeck et al., 2001). There are a number of numerical methods to 
estimate the posterior probability, the most commonly used is the Markov chain Monte Carlo 
(MCMC) method. There are two steps in the MCMC. First, a new tree is made randomly from 
the current tree, then either this tree is accepted or rejected based on a probability described by 
Metropolis et al. (1953) and Hastings (1970). This is repeated several times. MrModeltest 2.3 
compares 24 models of nucleotide substitution. The best-fit model was selected as 
recommended by the Akaike Information Criterion (AIC) in MrModeltest version 2.3 in the 
Bayesian analysis (Nylander, 2004). A model selection is the comparison of all models using 
AIC (Akaike, 1974). Each analysis was run for 3,000,000 generations with six Markov chains to 
achieve a mean standard deviation less than 0.01. Posterior probabilities (PP) were calculated, 
and the model parameters were stabilized at 2,400,000 generations. Trees were sampled every 
100 iterations. The final tree was visualized with FigTree v4.1.0 (FigTree: 
http://tree.bio.ed.ac.uk/software/figtree/) (Bahudhanapati et al., 2015). 
Neighbor joining and maximum likelihood trees were generated by using the algorithms 
included in the MEGA 6.0 software. The neighbor joining tree is a data clustering algorithm 
based on similarity and distance matrix. The bootstrap consensus trees were inferred from 





value added to each internal node of the tree. This represents the number of times that the 
branch clustering occurs in the replicate trees when they are resampled. The evolutionary 
distances were computed using the Poisson correction method and are in the units of the 
number of amino acid substitutions per site (Tamura et al., 2003). The evolutionary history was 
also inferred by using the maximum likelihood method based on the JTT matrix-based model 
(Zuckerkandl et al., 1965). In this method, the tree that has the highest probability of 
generating the observed data is selected. JTT is an amino acid replacement model used in 
maximum likelihood to find the probabilities of change on tree branches. Several studies 
showed that JTT model is useful for the analysis of evolutionary history of membrane proteins. 
Since ADAMs are transmembrane proteins so we used the JTT model (Jones et al., 1994). 
The percentage of trees in which the associated taxa clustered together is shown next to the 
branches. Initial trees were obtained by applying the neighbor joining and BioNJ algorithms to 
a matrix of pairwise distances using the JTT model, and then selecting the topology with 
superior log likelihood value.  JTT matrices used in this program MEGA6.0 were obtained from 
the source code of PHYLIP version 3.6 (Felsenstein et al., 1993-2001). All positions containing 
gaps and missing data were eliminated (Bahudhanapati et al., 2015). 
2.3. Syntenic analyses: 
For syntenic analyses, an individual Adam gene was entered into the search box of Genomicus 
(Louis et al., 2013), to find the position of tADAMs with respect to other genes for all the species 
mentioned above. Metazome (Jones et al., 1992) and the NCBI Map Viewer was also used to 
identify surrounding loci that are evolutionarily conserved. Data from these websites were 






2.4. Identification of retroposition event among 
the Adam genes: 
Using the UCSC Genome Browser BLAT search, potential retroposed Adam genes were 
identified as Adam genes with no or few (≤ 2) introns. ADAM protein sequences were obtained 
from NCBI, and the sequence was entered in the search bar of UCSC Genome Browser and the 
splice sites were determined (Bahudhanapati et al., 2015). 
3. RESULTS 
3.1. TAdams in various animal species: 
Four Adam genes have been identified in the Ciona genome and twenty-two in zebrafish, but 
tAdam has not been identified in these non-mammalian species (Huxley-Jones et al., 2007). 
TAdams had only been identified in eutherians, so we started looking for tAdams in non-
eutherian vertebrates. We performed a search for tAdam genes in various vertebrate species, 
including frog (Xenopus tropicalis), lizard (Anolis carolinensis), chick (Gallus gallus), opossum 
(Monodelphis domestica), mouse (Mus musculus) and human (Homo sapiens) (Table 2), to 
understand the mechanism of evolution and the origin of tAdams. We found five tAdams in 
chick, nine in lizard and nine in opossum. 
3.2. Story of ADAM9 and ADAM9-like: 
ADAM9 is overexpressed in many human carcinomas, and plays an important role in 
tumorigenesis and angiogenesis. ADAM9 cleaves molecules such as EGF, EphB4, Flk-1, 
CD40, etc. The cleaving of these molecules plays important roles in tumorigenesis and 





age, but do not show any apparent developmental defects. Similarly, null mutations in ADAM9 
result in cone-rod dystrophy in humans (Parry et al., 2009). We could not identify Adam9 in 
invertebrates like Drosophila and Ciona, but found the Adam9 gene in teleosts as well as 
spotted gar. The syntenic locations of the nearby genes of Adam9 in teleosts are rearranged 
relative to the position of Adam9 and its nearby genes in spotted gar, amphibians and higher 
vertebrates (Figure 3).  
We identified an Adam9-like gene in fish, amphibian, reptilian and avian genomes (Figure 4). 
We could not identify this gene in any mammals; hence it may have been lost in mammals 
(Figure 4). The protein sequences of ADAM9-like from various species are more similar to 
ADAM9 than to other somatic ADAMs. This suggests that ADAMs 9 and 9-like share a common 
ancestor. Adam9 and Adam9-like are absent in the jawless lampreys, but have been identified 
in the cartilaginous fish elephant shark, one of the earliest vertebrate species. We were unable 
to identify which of these ADAMs evolved first because of the lack of genomic data available, 
but it can be speculated that both ADAM9 and ADAM9-like evolved early during vertebrate 
evolution.  
3.3. Group I and Group II tADAMs cluster with 
ADAMs 9 and 9-like forming a subfamily: 
Through an extensive search, we identified Group I and Group II tAdams in Anolis, chicken and 
opossum. Both Group I and Group II tADAMs of Anolis, chicken, opossum, mouse and human 
form clusters with high confidence with ADAMs 9 and 9-like in phylogenetic trees (Figure 2). In 
Xenopus tropicalis and fish genomes, we could not identify any definitive Group I or Group II 
tADAM, although ADAM16 of Xenopus laevis has been reported to be expressed predominantly 





(Figure 2A). From the study, it can be said that Group I and Group II tADAMs and both the 
ADAM9 and ADAM9-like belong to the same ADAM subfamily. Since ADAM9 and ADAM9-like 
are found in all non-mammalian vertebrates including fishes and amphibians, both ADAM9 and 
9-like probably emerged earlier than the tADAMs during vertebrate evolution, suggesting that 
Group I and Group II tADAMs evolved from ancient ADAM9 and/or 9-like. 
In the previous study by Cho (2012), Adams 7 and 28 were classified under the tAdams as 
“reproductive” Adams. Cho classified the tAdams into three groups which we have mentioned 
earlier. The Group III consists of Adam 7 and 28, and was called reproductive Adams because 
Adam7 is predominantly expressed in the mouse epididymis (Cho, 2012). However, exploring 
the UniGene database, we found that human Adam28 is expressed in a wide variety of somatic 
tissues (data not shown). The phylogenetic analyses strongly indicate that ADAM 7 and 28 do 
not cluster with the tADAMs in the phylogenetic tree. This evidence suggests that they not 
belong to the subfamily that includes ADAMs 9, 9-like and tADAMs. Group III, which consists of 
ADAM 7 and 28 based on Cho’s classification of  “reproductive” ADAMs was removed and 
excluded from subsequent analyses. 
3.4. Evolution of Group II tAdam genes: 
We carried out a syntenic comparison of Group II tAdams for all representative amniote species 
and found that Group II tAdams cluster together in a genomic region next to Adam9 (Figure 4). 
We found two Group II tAdam genes in the lizard (Anolis carolinensis) and chicken (Gallus 
gallus) genomes. Three Group II tAdams were found in opossum, four in mouse, and five in the 
human genome. It is only in the mouse and rat genomes that the Adam2 gene is on a different 
chromosome (chromosomes 14 and 15, respectively), but all the other Group II tAdams are 
localized near Adam9 (Figure 3). No Adam gene was found near the locus of Adam9 in the X. 





duplication i.e. the event of copying the gene adjacent to the original copy; gave rise to Group II 
tAdam genes, and that an ancient Adam9 was the founder gene of the very first Group II tAdam 
during evolution. Unequal crossing over during homologous recombination between paralogous 
sequences gives rise to tandemly duplicated genes. Deletion and inversion of genes are also 
the result of unequal crossing over in homologous recombination. The organization of Group II 
tAdam genes in an array on the same genomic locus is mainly a result of tandem duplication. 
Gene duplication also gives rise to pseudogenes. In the human genome, among the Group II 
tAdams we found that Adam3 and Adam5 are pseudogenes (HGNC: 
http://www.genenames.org/). 
3.5. Evolution of Group I tAdam genes: evidence 
for retroposition: 
A characteristic of Group I tAdams is that they contain none or very few introns. Retroposition is 
a mechanism in which a messenger RNA is reverse transcribed into cDNA with the help of 
reverse transcriptase, then the newly transcribed intronless DNA sequence from the mRNA gets 
inserted into the genome.  Since the events in retroposition lead to intronless genes, it has been 
speculated that Group I tAdams are derived from retroposition. These Group I tAdams have lost 
the signature of retroposed genes i.e., the poly A tail because they evolved a long time ago. In 
our phylogenetic study, Group I tADAMs cluster with ADAM9 and 9-like and Group II tADAMs, 
so it can be speculated that Group I tADAMs share a common ancestor with Group II tADAM, 
ADAM9 and 9-like. Thus, the parental gene that gave rise to a specific Group I tAdam could be 






3.6. A recent event of retroposition*: 
[*Note: This is Dr. Hari Bahudhanapti’s work.] 
We started looking for retroposed genes in the chicken, lizard, opossum, mouse and human that 
were derived from the ADAM9/9-like/tADAM subfamily in which the characteristic features of 
retroposition may still be well preserved. 
In the opossum genome, we identified an additional copy of Adam9 that has only one intron, 
which we named “Adam9b” (Figure 5). This gene is ~99% identical to another copy, i.e. 
Adam9a, as per their nucleotide sequences. The Adam9a gene has 24 introns and conserved 
exon/intron boundaries with Adam9 in other vertebrate species (data not shown), hence is the 
opossum orthologue of Adam9. Since Adam9b has only one intron and a very high sequence 
homology to Adam9a, we believe that Adam9b was likely retroposed. We also found a polyA tail 
in Adam9b (Figure 5) which supports the recent retroposition of Adam9b. In the event of 
retroposition, the cDNA copy is inserted randomly and the non-LTR retroposons like LINE has 
an adenosine-rich region at their 3’ends. Since Adam9b has a polyA tail and is almost 
intronless, it indicates that it is a retroposed gene. We could not identify any other retroposed 
copy of other Adams in the opossum genome. This suggests that Adam9 may be a preferred 
target for retroposition.  
3.7. Tandem duplication of Group I tAdams:  
The Group I tAdams were found in clusters in some species. An example is Adam1 duplication. 
Genes near the Adam1 locus are conserved from frogs to humans, although Adam1 was not 
found in Xenopus tropicalis in this genomic region. This region in mammals and chicks is 





carolinensis has one Adam1, while the Chinese turtle has a duplicated Adam1 (Figure 6). Two 
copies of Adam1 are present in the chicken, opossum, mouse and human genome, suggesting 
tandem duplication. However, no orthology was found between mammalian and chicken 
Adam1a and 1b. So we hypothesize that either Adam1 has been duplicated separately in 
chicken and mammals, or before the divergence of mammals and one copy of it was lost in 
certain species such as Anolis carolinensis (Figure 6) (Bahudhanapati et al., 2015). 
4. Discussion: 
Gene duplication arises from unequal crossing over, retroposition, or chromosomal (or genome) 
duplication. These three different processes generate three different outcomes. Unequal 
crossing over results in tandem duplication, i.e. duplicated genes are present on the same 
chromosome close to each other. Position of crossing over determines whether the duplicated 
region has an entire gene or not. Retroposition can be characterized by loss of introns, loss of 
regulatory sequences, presence of polyA tails, or presence of flanking short direct repeats.  
Pseudogenization or the loss of function of the duplicated gene is a common feature of gene 
duplication. We found 11 tAdam pseudogenes, which include both Group I and Group II tAdam 
genes (HGNC: http://www.genenames.org). These Group I tAdams which have probably 
originated from the event of retroposition, have a pre-mature stop codon. They are expressed 
and produce a truncated protein which is non-functional. So these Group I tAdams are not 
pseudogenes because of lack of transcription, which is commonly seen in retroposed genes 
since they do not carry the regulatory elements essential for transcription (Kaessmann et al., 
2009). In retroposition, there is always a chance of insertion of the cDNA into a genomic 
location that is downstream of a promoter sequence; hence, causes the retroposed genes to get 





are commonly found to be expressed in the testes (Kaessmann et al., 2009, Vinckenbosch et 
al., 2006).   
Gene duplication can work in two ways that can lead to evolution. One way is that the 
duplicated gene copy is producing proteins for a new function and the process is called 
neofunctionalization, or the multiple functions of the ancestral gene are divided into the newly 
duplicated genes and it is called subfunctionalization. The process of neofunctionalization will 
sustain if the new functions are advantageous. These duplicated tAdam genes which are 
predominantly expressed in testis, may also expand their expression to other tissues. It was 
found from the UniGene database, that Group II tAdams of mouse and human have transcripts 
expressed in some somatic tissues (Table 3). 
5. CONCLUSION 
In this study, we identified homologues of mouse and human tADAMs in the non-mammalian 
vertebrates chicken, lizard, and non-placental mammals such as the opossum. From our 
phylogenetic analyses, we found that the tADAMs cluster with ADAM9 as well as ADAM9-like, 
which we identified only in the non-mammalian vertebrates. It can be suggested that all the 
tADAMs have originated from an ancient somatic ADAM9. TADAMs were classified into three 
groups. We proposed to remove Group III, consisting of ADAM7 and ADAM28 from the 
classification because in our phylogenetic analyses Group III did not cluster with the tADAMs. 
We infer from our phylogenetic analyses that ADAMs 7 and 28 do not belong to the subfamily 
that includes ADAMs 9, 9-like and tADAMs. 
The Group I tAdams are intronless, and are likely derived from retroposed transcripts, and some 
have undergone further tandem duplication in some vertebrates. One example of tandem 





a single chromosomal region (Bahudhanapati et al., 2015).  Phylogenetic analyses indicate that 
the Group I tAdams share a common ancestor with the Group II tAdams, Adam9 and 9-like. 
Thus, the parental gene that gave rise to a specific Group I tAdam could be Adam9, 9-like, a 
Group II tAdam, or another Group I tAdam. Group II tAdams cluster together in a genomic 
region next to Adam9 suggesting that tandem duplication from an ancient Adam9 gave rise to 
all the Group II tAdams.  
We found an intronless Adam9b containing a polyA tail in opossum, which represents one of the 
most recent retroposition events. Retroposed elements are found in high percentage in the 
opossum genome (Mikkelsen et al., 2007). But we could not identify any other retroposed copy 
of other Adams in the opossum genome. The tAdam loci are prone to duplication and 
retroposition and hence provide excellent examples for studying gene duplication and evolution. 
In the future, it would be interesting to study the expression and function of the non-eutherian 


















Figure 1: Structure of ADAM. The domain structure comprises of SP (signal peptide), PRO 
(prodomain), MP (metalloproteinase domain), DIS (disintegrin domain), CRD (cysteine-rich 

















Figure 2A: Bayesian tree of ADAMs for frog (Xenopus tropicalis). 
 













Figure 2C: Bayesian tree of ADAMs for chicken (Gallus gallus)  
 
 















Figure 2E: Bayesian tree of ADAMs for mouse (Mus musculus). 
 
 

















Figure 3: Syntenic analyses of the Group II tAdams. Most of the Group II tAdams lie next to 













Figure 4: Syntenic analysis of Adam9-like gene. Syntenic analysis of Adam9-like copy from 
lower non-mammalian vertebrates to cartilaginous elephant shark showed that it is highly 










Figure 5: Comparison between Adam9a and Adam9b of opossum. (A) Location of Adam 9a and 
9b in the opossum genome. (B) Comparison table of Adam9a and Adam9b of opossum. (C) The 
gene structure of Adam9b. The Adam9b pseudogene contains a polyA sequence, and the only 
intron was identified as an opossum retroposon (Mdo3LTR1a/ERV1), which was likely inserted 
after the original retroposition event that generated Adam9b. The structure of the ADAM9a 
mRNA is shown. The black vertical lines in ADAM9a mRNA represent splice sites (Courtesy of 














Figure 6: Adam1 duplication. Expansion of Adam1 through tandem duplication in chicken, 
opossum and mouse genome. Adam1 gene is not found in the X. tropicalis genome and only 


















Table 1: Classification of mouse tADAMs.  
 
Group ADAMs 
 I 1, 4, 6, 20, 21, 24, 25, 26, 29, 
30, and 34 
 II 2, 3, 5, 18 and 32 
 























Table 2. Accession numbers of ADAM proteins used in phylogenetic analyses. 
 
   Species Protein Name  Accession Number 
Human ADAM2 Q99965 
Human ADAM7  Q9H2U9 
Human ADAM8  P78325 
Human ADAM9  Q13443 
Human ADAM10  O14672 
Human ADAM11 O75078 
Human ADAM12 O43184 
Human ADAM15  Q13444 
Human ADAM17 P78536 
Human ADAM18 Q9Y3Q7 
Human ADAM19 Q9H013 
Human ADAM20 O43506 
Human ADAM21 Q9UKJ8 
Human ADAM22  Q9P0K1 
Human ADAM23 O75077 
Human ADAM28  Q9UKQ2 
Human ADAM29 Q9UKF5 
Human ADAM30  Q9UKF2 
Human ADAM32 Q8TC27 
Human ADAM33  Q9BZ11 
   Mouse ADAM1a Q60813 
Mouse ADAM1b Q8R534 
Mouse ADAM2 Q60718 
Mouse ADAM3 NP_033749 
Mouse ADAM4a AAN77877 
Mouse ADAM4b NP_001034084 
Mouse ADAM5   Q3TTE0 
Mouse ADAM6a  NP_777479 
Mouse ADAM6b  NP_001009545 
Mouse ADAM7 O35227 
Mouse ADAM8 Q05910.3 
Mouse ADAM9 NP_001257925 
Mouse ADAM10 O35598.2 
Mouse ADAM11 Q9R1V4.2 





Mouse ADAM15 NP_001257925 
Mouse ADAM17 Q9Z0F8.3 
Mouse ADAM18  Q9R157 
Mouse ADAM19 O35674.2 
Mouse ADAM21 Q9JI76 
Mouse ADAM22 Q9R1V6.2 
Mouse ADAM23 Q9R1V7.1 
Mouse ADAM28 Q9JLN6.3 
Mouse ADAM29 Q811Q4 
Mouse ADAM30          AAO38664 
Mouse ADAM32 Q8K410 
Mouse ADAM33 Q923W9.3  
Mouse TESTASE1/ADAM24 Q9R160 
Mouse TESTASE2/ADAM25    Q9R159 
Mouse TESTASE3a/ADAM26a EQR158.2 
Mouse TESTASE3b/ADAM26b NP_001009547 
Mouse TESTASE4/ADAM34 NP_665688 
Mouse TESTASE6/ADAM36 CAD65874 
Mouse TESTASE7/ADAM37 CAD65875 
Mouse TESTASE8 /ADAM38 AAI50794 
Mouse TESTASE9/ADAM39 NP_001020551 
   Opossum ADAM1a    XP_001371130.2 
Opossum ADAM1b XP_001379089.1 
Opossum ADAM2 XP_007476447.1 
Opossum ADAM4 XP_001376240.1 
Opossum ADAM7 XP_001372800.2 
Opossum ADAM8    XP_007486259.1 
Opossum ADAM9a XP_001381888.1  
Opossum ADAM9b XP_001371117.2 
Opossum ADAM10  XP_001377651.2 
Opossum ADAM11 XP_001375121.2    
Opossum ADAM12  XP_001367874.2    
Opossum ADAM15 XP_007482077 
Opossum ADAM17  XP_007476214.1 
Opossum ADAM18 XP_007476434 
Opossum ADAM19 XP_007474485 
Opossum ADAM20  XP_001376230 
Opossum ADAM22  XP_007505027 
Opossum ADAM23 XP_001370554 
Opossum ADAM28 XP_007477887 
Opossum ADAM30a  XP_007485363 





Opossum ADAM30c XP_001367215 
Opossum ADAM30d   XP_001376215.1 
Opossum ADAM32 XP_007476443 
Opossum ADAM33 XP_007496940 
   Chicken ADAM8  XP_421552.4  
Chicken ADAM9 NP_001026567.2 
Chicken ADAM9L XP_421805.4  
Chicken ADAM10 NP_989592.2 
Chicken ADAM11 XP_425842.4 
Chicken ADAM12 NP_001136322.1 
Chicken ADAM13 NP_001075887.1 
Chicken ADAM17 NP_001026567.2 
Chicken ADAM19  NP_001182051.1 
Chicken ADAM22 NP_001138700.1 
Chicken ADAM23  NP_001138702.1 
Chicken ADAM28    XP_004947615.1 
Chicken GrII tADAM1 XP_004947684.1 
Chicken GrII tADAM2 XP_003642600.2 
Chicken GrI tADAM1 NP_001264719.1   
Chicken GrI tADAM2 NP_996860.1 
Chicken GrI tADAM3 XP_003642244.2  
   Anolis GrI tADAM1 XP_003228944.1 
Anolis GrI tADAM2 XP_008116367.1 
Anolis GrI tADAM3 XP_003225712.1 
Anolis GrI tADAM4 XP_008115539.1 
Anolis GrI tADAM5 XP_008116366.1 
Anolis GrI tADAM6 XP_008107167.1 
Anolis GrI tADAM7 XP_008116368.1 
Anolis GrII tADAM1 ENSACAG00000009283* 
Anolis GrII tADAM2 ENSACAG00000029425* 
Anolis ADAM9 XP_003226892.1 
Anolis ADAM9-L     XP_008104933.1 
Anolis ADAM10 XP_003228118.1 
Anolis ADAM11  XP_003222558.1 
Anolis ADAM12 XP_003218654.1 
Anolis ADAM13  XP_008120251.1 
Anolis ADAM17 XP_008115827.1 
Anolis ADAM19   XP_003223525.1 
Anolis ADAM22 XP_008110692.1 
Anolis ADAM23 XP_003223597.1 





   Xenopus ADAM9  NP_001233130.1 
Xenopus ADAM9-L     XP_004915886.1 
Xenopus ADAM10  NP_001037869.1 
Xenopus ADAM11   NP_001243157.1  
Xenopus ADAM12   ABD52382.1 
Xenopus ADAM13  NP_001035102.1 
Xenopus ADAM15    ADK56765.1 
Xenopus ADAM16  AAI70249.1 
Xenopus ADAM17 NP_001182159.1 
Xenopus ADAM19 NP_001035105.1 
Xenopus ADAM22    O42596.2 
Xenopus ADAM23 NP_001233135.1 
Xenopus ADAM28a NP_001120446.1 
Xenopus ADAM28b          NP_001233133.1 
   Platypus  ADAM9  XP_001519072.2 
   Zebrafish ADAM9 NP_001004678.1 
Zebrafish ADAM9-L     NP_001107911.1 
   Medaka  ADAM9 XP_004072878.1 
Medaka  ADAM9-L     XP_004080608.1 
   Shark           ADAM9 XP_007902115.1 
Shark           ADAM9-L     XP_007883217.1 
   
 
























adipose tissue  649 1/1540 77 1/12866
adrenal gland -- -- 60 2/32940
ascites -- -- 75 3/39834
bladder 429 7/16283 133 4/29860
bone 440 15/34066 -- --
bone marrow 29 4/136333 -- --
brain 33 16/475384 21 24/1092688
connective tissue 504 10/19807 120 18/149072
embryonic tissue 112 76/677554 56 12/212896
epididymis 322 1/3101 -- --
eye 80 15/185387 23 5/208840
heart 36 2/54558 44 4/89524
mammary gland 141 43/303048 -- --
nerve -- -- 128 2/15535
testis 32 4/121820 27 12/435204
uterus 291 2/6855 21 5/232093
sympathetic ganglion 400 4/9989 -- --
vascular -- -- 271 14/51649
brain -- -- 1 2/1092688
connective tissue -- -- 20 3/149072
lungs 10 1/99799 -- --
prostate -- -- 10 2/189536
testis 147 36/435204 82 36/435204
thymus 2 1/121153 -- --
brain -- -- 3 4/1092688
spleen 86 8/92417 -- --
testis 1264 154/121820 117 51/435204
connective tissue 50 1/19807 46 7/149072
eye  5 1/185387 -- --
testis  582 71/121820 68 30/435204
bladder -- -- 33 1/29860
connective tissue -- -- 46 7/149072
embryonic tissue -- -- 9 2/212896
testis 82 10/121820 64 28/435204
adipose tissue -- -- 77 1/12866
brain  -- -- 3 4/1092688
connective tissue -- -- 114 17/149072
embryonic tissue 7 5/677554 -- --
kidney -- -- 4 1/210778















1. Bahudhanapati H, Bhattacharya S, and Wei S; Evolution of vertebrate Adam genes; 
duplication of testicular Adams from ancient Adam9/9-like loci. PlosOne, 2015, 10(8) 
2. BLAT: https://genome.ucsc.edu/cgi-bin/hgBlat?command=start. 
3. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black 
RA, Israël A. “A novel proteolytic cleavage involved in Notch signaling: the role of the 
disintegrin-metalloprotease TACE”. Mol Cell. 2000, 5 
4. Black RA. “Tumor necrosis factor-alpha converting enzyme”. Int J Biochem Cell Biol. 
2002, 34 (1): 1-5. 
5. Brachvogel B, Reichenberg D, Beyer S, Jehn B, von der Mark K, Bielke W. “Molecular 
cloning and expression analysis of a novel member of the Disintegrin and 
Metalloprotease-Domain (ADAM) family”. Gene 2003, 288, 203–210. 
6. Brocker CN, Vasiliou V, Nebert DW. “Evolutionary divergence and functions of the 
ADAM and ADAMTS gene families”. Human Genomics. 2009, 1. 43 –55 
7. Bond JS, Beynon RJ. “The astacin family of metalloendopeptidases.” Protein Sci. 1995, 
1247-61. 
8. Borroto A, Ruiz-Paz S, de la Torre TV, Borrell-Pages M, Merlos-Suarez A, Pandiella A, 
Blobel CP, Baselga J, Arribas J. “Impaired trafficking and activation of tumor necrosis 
factor-alpha-converting enzyme in cell mutants defective in protein ectodomain 
shedding”. J Biol Chem. 2003, 278(28) 
9. Bode W, Grams F, Reinemer P, Gomis-Rüth FX, Baumann U, McKay DB, Stöcker W.  





10. Blobel CP, Wolfsberg TG, Turck CW, Myles DG, Primakoff P, White JM. “A potential 
fusion peptide and an integrin ligand domain in a protein active in sperm-egg fusion”. 
Nat. 1992, 356: 248-252. 
11.  Cousin H, Abbruzzese G, Kerdavid E, Gaultier A, Alfandari D. "Translocation of the 
cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression 
and cranial neural crest cell migration." Dev Cell. 2011, 20(2): 256-263. 
12. Cong L, Jia J. “Promoter polymorphismsbond which regulate ADAM9 transcription are 
protective against sporadic Alzheimer's disease”. Neurobiol Aging. 2009, 32 (1) 
13.  Cho C. “Testicular and epididymal ADAMs: expression and function during fertilization”. 
Nat Rev Urol. 2012, 9: 550-560. 
14.  Cao Y, Kang Q, Zolkiewska A. “Metalloprotease-disintegrin ADAM 12 interacts with 
alpha-actinin-1”.Biochem J.  2001, 353-61. 
15. Cerretti DP, DuBose RF, Black RA, Nelson N. “Isolation of two novel metalloproteinase-
disintegrin (ADAM) cDNAs that show testis-specific gene expression.” Biochem Biophys 
Res Commun.1999, 263(3):810-5. 
16. Choi I, Woo JM, Hong S, Jung YK, Kim DH, Cho C. “Identification and characterization 
of ADAM32 with testis-predominant gene expression”. Gene. 2003,304:151-162. 
17. Choi H, Lee B, Jin S, Kwon JT, Kim J, Jeong J. “Identification and characterization of 
promoter and regulatory regions for mouse Adam2 gene expression”. Mol Biol Rep. 
2013, 40:787–796.  
18. Edwards DR, Handsley MM, Pennington CJ. “The ADAM metalloproteinases”. Mol 
Aspects Med. 2008, 29(5): 258-289. 
19. Eto K, Huet C, Tarui T, Kupriyanov S, Liu HZ, Puzon-McLaughlin W, Zhang 





conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding 
and other cell interactions”. J Biol Chem. 2002, 277(20):17804-10.  
20.  Evans, J. P. “The molecular basis of sperm-oocyte membrane interactions during 
mammalian fertilization”. Hum. Reprod. 2002, 8, 297–311. 
21. Evans J.P. “ Fertilin β and other ADAMs as integrin ligands: Insights into cell adhesion 
and fertilization”. BioEssays, 2001, 23: 628–639. 
22. Edgar RC. “MUSCLE: multiple sequence alignment with high accuracy and high 
throughput”. Nucleic Acids Res. 2004, 32: 1792-1797. 
23. Frayne J, Jury JA, Barker HL, Hall L. “The MDC family of proteins and their processing 
during epididymal transit”. J Reprod Fertil Suppl. 1998, 53:149-55. 
24. FigTree: http://tree.bio.ed.ac.uk/software/figtree/ 
25. Gaultier A., Cousin H., Darribere T., Alfandari D. “ADAM13 disintegrin and cysteine-rich 
domains bind to the second heparin-binding domain of fibronectin”. J. Biol. Chem. 2002, 
277 (26), 23336–44 
26. Huxley-Jones J, Clarke TK, Beck C, Toubaris G, Robertson DL,  Boot-Handford RP. 
“The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio 
rerio”. BMC Evol Biol. 2007, 7: 63. 
27. Hooper NM. “Families of zinc metalloproteases”. FEBS. 1994, 354 (1) 
28. Han C, Choi E, Park I, Lee B, Jin S, Kim do H, Nishimura H, Cho C. “Comprehensive 
analysis of reproductive ADAMs: relationship of ADAM4 and ADAM6 with an ADAM 
complex required for fertilization in mice”. Biol Reprod. 2009, 80(5):1001-8 
29. Huelsenbeck John., Rannala B, and Masly PJ., “An Introduction to Bayesian Inference of 
Phylogeny”. http://www.sciencemag.org/site/feature/data/1050262.pdf 
30. Jin P, Panelli MC, Marincola FM, Wang E. “Cytokine polymorphism and its possible 





31. Jones DT, Taylor WR, Thornton JM. “The rapid generation of mutation data matrices 
from protein sequences”. Comput Appl Biosci. 1992, 8: 275-282. 
32. Jones D.T, Taylor W.R, Thornton J.M. “A mutation data matrix for transmembrane 
proteins”. FEBS Lett.1994, 339:269–275. 
33. Kaessmann H, Vinckenbosch N, Long M. “RNA-based gene duplication: mechanistic 
and evolutionary insights”. Nat Rev Genet. 2009, 10: 19-31. 
 
34. Kim T, Oh J, Woo JM, Choi E, Im SH, Yoo YJ, Kim DH, Nishimura H, Cho C. 
“Expression and relationship of male reproductive ADAMs in mouse”. Biol Reprod. 2006, 
74(4):744-50 
35. Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast 
cancer. J Clin Invest. 2007, 117 (2):337-45 
36. Kurisaki T, Masuda A, Sudo K, Sakagami J, Higashiyama S, Matsuda Y, Nagabukuro 
A, Tsuji A, Nabeshima Y, Asano M, Iwakura Y, Sehara-Fujisawa A. “Phenotypic analysis 
of Meltrin alpha (ADAM12) -deficient mice: involvement of Meltrin alpha in adipogenesis 
and myogenesis”. Mol Cell Biol. 2003, 23(1) 
37.  Kurzrock R. “Cytokine deregulation in cancer”. Biomed Pharmacother. 2001, 55:543 – 
744. Black RA. “Tumor necrosis factor-alpha converting enzyme”. Int J Biochem Cell 
Biol. 2001, 34 (1): 1-5. 
38. Louis A, Muffato M, Roest Crollius H. “Genomicus: five genome browsers for 
comparative genomics in eukaryote”. Nucleic Acids Res. 2013, 700-5 
39. Liebmann C. “EGF receptor activation by GPCRs: an universal pathway reveals different 
versions.” Mol Cell Endocrinol. 2011, 15;331(2):222-31  
40. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper 





epithelial cell-cell adhesion, migration, and beta-catenin translocation.” Proc Natl Acad 
Sci. U S A, 2005, 102  
41. Murase S, Cho C, White JM, Horwitz AF. “ADAM2 promotes migration of neuroblasts 
in the rostral migratory stream to the olfactory bulb”. Eur J Neurosci. 2008, 27(7). 
42. Mikkelsen TS, Wakefield MJ, Aken B, Amemiya CT, Chang JL, et al. “Genome of the 
marsupial Monodelphis domestica reveals innovation in non-coding sequences”. Nat. 
2007, 447: 167-177. 
43. Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee IS, Hase T, Matsubara H. 
Cloning and sequencing of Serratia protease gene. Nucleic Acids Res. 1986, 
14(14):5843-55 
44. Primakoff P, Hyatt H, Tredick-Kline J. “Identification and purification of a sperm surface 
protein with a potential role in sperm-egg membrane fusion”. J Cell Biol. 1987, 104: 141-
149 
45. Primakoff P, Myles DG. “The ADAM gene family: surface proteins with adhesion and 
protease activity”. Trends Genet. 2000, 16(2):83-7. 
46. ProteinBLAST[http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=
BlastSearch&LINK_LOC=blasthome] 
47. Peduto L. “ADAM9 as a potential target molecule in cancer”. Curr Pharm Des. 2009, 15 
(20): 2282-7. 
48.  Parry DA, Toomes C, Bida L, Danciger M, Towns KV,  McKibbin M, Jacobson 
SG, Logan CV, Ali M, Bond J, Chance R, Swendeman S, Daniele LL, Springell K,Adams 
M, Johnson CA, Booth AP, Jafri H, Rashid Y, Banin E, Strom TM, Farber DB, Sharon 
D, Blobel CP, Pugh EN Jr, Pierce EA, Inglehearn CF. “ Loss of the metalloprotease 
ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice”. Am J 





49. Rooke J, Pan D, Xu T, Rubin GM. “KUZ, a conserved metalloprotease-disintegrin protein 
with two roles in Drosophila neurogenesis”. Sci. 1996, 273(5279). 
50. Roghani M, Becherer JD, Moss ML, Atherton RE, Erdjument-Bromage H, Arribas 
J, Blackburn RK, Weskamp G, Tempst P, Blobel CP. Metalloprotease-Disintegrin MDC9: 
Intracellular Maturation and Catalytic Activity. J. Biol. Chem. 1999, 274:3531–3540. 
51. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, Saftig P. 
“ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin 
nuclear signalling”. EMBO J. 2005, 24, 
52. Ronquist F, Huelsenbeck JP. “MrBayes 3: Bayesian phylogenetic inference under mixed 
models”. Bioinformatics 2003, 19: 1572-1574. 
53. Repeatmasker: http://www.repeatmasker.org. 
54. Shilling FM, Kratzschmar J, Cai H, Weskamp G, Gayko U,  Leibow J, Myles 
DG, Nuccitelli R, Blobel CP. “Identification of metalloprotease/disintegrins in Xenopus 
laevis testis with a potential role in fertilization”. Dev Biol. 1997, 186: 155-164. 
55. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann 
D, Saftig P, Blobel CP. “Distinct roles for ADAM10 and ADAM17 in ectodomain shedding 
of six EGFR ligands.” J Cell Biol. 2004, 164. 
56. Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW. “Tumor 
necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): 
implications for neuron-glia interactions during neurodegeneration”. J Neurosci. 2000, 
20(21):7964-71. 
57. Schlondorff J., Blobel C.P. “Metalloprotease-disintegrins: Modular proteins capable of 
promoting cell–cell interactions and triggering signals by protein-ectodomain shedding”. 





58. Schiffmacher AT, Padmanabhan R, Jhingory S, Taneyhill LA. “Cadherin-6B is 
proteolytically processed during epithelial-to-mesenchymal transitions of the cranial 
neural crest”. Mol Biol Cell. 2014, 25(1) 
59. Seals DF, Courtneidge SA. “The ADAMs family of metalloproteases: multidomain 
proteins with multiple functions”. Genes & Dev. 2003, 17: 7-30 
60. Stocker, W., Grams, F., Baumann U., Reinemer  P., Gomis-Ruth  F. X.,McKay, D. B. 
and Bode, W. “The metzincins – topological and sequential relations between the 
astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of 
zinc-peptidases”. Protein Sci. 1995, 823-840. 
61. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. “MEGA6: Molecular Evolutionary 
Genetics Analysis version 6.0.” Mol Biol Evol. 2003, 30: 2725-2729. 
62. Vinckenbosch N, Dupanloup I, Kaessmann H.  “Evolutionary fate of retroposed gene 
copies in the human genome”. Proc Natl Acad Sci U S A.  2006, 103: 3220-3225. 
 
63. Wolfsberg TG, Bazan JF, Blobel CP, Myles DG, Primakoff P, White JM. “The precursor 
region of a protein active in sperm-egg fusion contains a metalloprotease and a 
disintegrin domain: structural, functional, and evolutionary implications”. Proc Natl Acad 
Sci U S A. 1993, 90: 10783-10787. 
64. Wolfsberg TG, Straight PD, Gerena RL, Huovila AP, Primakoff P,  Myles DG, White JM.  
“ADAM, a widely distributed and developmentally regulated gene family encoding 
membrane proteins with a disintegrin and metalloprotease domain”. Dev Biol. 1995, 169: 
378-383. 
65. White JM. “ADAMs: modulators of cell-cell and cell-matrix interactions”. Curr Opin Cell 





66.  Wong RW.  “Transgenic and knockout mice for deciphering the roles of EGFR ligands”. 
Cell Mol Life Sci. 2003, 60(1):113-8. 
67. Wei S, Whittaker CA, Xu G, Bridges LC, Shah A, White JM, Desimone DW. 
“Conservation and divergence of ADAM family proteins in the Xenopus genome”. BMC 
Evol Biol. 2010, 10:211 
68. Yi C, Woo JM, Han C, Oh JS, Park I, Lee B, Jin S, Choi H, Kwon JT, Cho BN, Kim do 
H, Cho C. “Expression analysis of the Adam21 gene in mouse testis”. Gene Expr 
Patterns. 2010, 10(2-3):152-8. 
69. Zhu G.Z., Lin Y., Myles D.G., Primakoff P. “Identification of four novel ADAMs with 
potential roles in spermatogenesis and fertilization”. Gene 1999, 234, 227–237. 
70. Zhu GZ, Gupta S, Myles DG, Primakoff P.”Testase1 (ADAM 24) a Sperm Surface 
Metalloprotease Is Required for Normal Fertility in Mice”. Mol Reprod Dev. 2009, 
76:1106–1114 
71. Zhu GZ, Myles DG, Primakoff P.  “Testase 1 (ADAM 24) a plasma membrane-anchored 
sperm protease implicated in sperm function during epididymal maturation or 
fertilization”. J Cell Sci. 2001;114 
72. Zuckerkandl E, Pauling L., “Evolutionary divergence and convergence in proteins". 




















































































































Figure 15: Neighbor joining tree of ADAM9 for all tested vertebrates. 
 
